Can be used where 'the prognosis is very dismal, under both expanded access compassionate use and in a planned randomized controlled trial'.
We are taking on the sickest of the sick. This is very brave. I feel nervous for the company as a poor result could be detrimental, but also very proud.
- Forums
- ASX - By Stock
- Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
Can be used where 'the prognosis is very dismal, under both...
-
- There are more pages in this discussion • 289 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.39 |
Change
-0.065(4.47%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
$1.43 | $1.43 | $1.39 | $2.233M | 1.593M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 176754 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 4702 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 184754 | 1.390 |
15 | 102245 | 1.385 |
30 | 229555 | 1.380 |
11 | 26917 | 1.375 |
10 | 116439 | 1.370 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 2304 | 5 |
1.400 | 75416 | 16 |
1.405 | 40449 | 10 |
1.410 | 145497 | 11 |
1.415 | 77446 | 7 |
Last trade - 12.34pm 16/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online